6
No Boundaries
DURING THOSE FIRST THREE MONTHS OF 2020, BANCEL jumped from Davos to Washington to Cambridge, trying to marshal support (and dollars) for developing a vaccine against the new Disease X. He met with Dr. Anthony Fauci and others at the government’s infectious-disease research institute, who signaled they were ready to partner, using Disease X as the “stopwatch drill” for rapid vaccine development they had previously planned to do anyway with the Nipah virus.
He also met with his own board of directors and executive team, who were less certain. It would be a significant pivot for the company and carried opportunity costs vis à vis other projects in the pipeline. All of them remembered the last time Moderna tried to do this, with ...